| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-14 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-11 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-10 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-10 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |